Li Haichong,Yao Ziming,Guo Ruolan,et al.Genotypes and clinical intervention of patients with neurofibromatosis type 1 associated dystrophic scoliosis[J].Journal of Clinical Pediatric Surgery,2025,(04):312-319.[doi:10.3760/cma.j.cn101785-202410023-003]
Genotypes and clinical intervention of patients with neurofibromatosis type 1 associated dystrophic scoliosis
- Keywords:
- Neurofibromatosis Type1; Spinal Deformities; Genetic Testing; Genetic Research; Surgical Procedures; Operative; Treatment Outcome; Child
- Abstract:
- Objective To explore the genotypic characteristics of children with neurofibromatosis type 1 (NF1) associated dystrophic scoliosis and summarize the outcomes of surgery.Methods Whole exome sequencing (WES),multiplexligation-dependent probe amplification (MLPA) and whole genome Sequencing (WGS) was utilized for genotypic identification.A total of 47 children were operated for spinal deformities and the outcomes of surgery summarized by examining the clinical and imaging parameters before and after surgery.Results Twenty-three boys and 24 girls were clinically diagnosed as NF1 associated scoliosis with common symptoms including café-au-lait spots and scoliosis.NF1 mutations were detected in 43(91.5%) children,including 16 nonsense mutations,9 splicing mutations,13 frame shift mutations,2 missense mutation,2 exon deletions and 1 exon duplication.Initial surgical procedures included growing-rod surgery (n=30) and posterior spinal fusion (n=17).The follow-up duration was 3.6 years and Cobb angle of main curve improved from 56.0(43.0,65.0)° pre-operatively to 17.0(8.0,25.0)° at the last follow-up with an average correction rate of (68.6±17.5)%.The complications occurred in 9 patients during follow-ups.Conclusions In children with scoliosis fulfilling the clinical diagnostic criteria for NF1,the mutation detection rate of WES,MLPA,WGS was 91.5%.There is no mutation hotspot in NF1 gene.Molecular diagnosis may offer information about genetic counseling,prenatal diagnosis and eugenics.Surgery based upon patient age and severity may effectively correct spinal deformities.
References:
[1] Cimino PJ,Gutmann DH.Neurofibromatosis type 1[J].Handb Clin Neurol,2018,148:799-811.DOI:10.1016/B978-0-444-64076-5.00051-X.
[2] Bianchessi D,Ibba MC,Saletti V,et al.Simultaneous detection of NF1,SPRED1,LZTR1,and NF2 gene mutations by targeted NGS in an Italian cohort of suspected NF1 patients[J].Genes (Basel),2020,11(6):671.DOI:10.3390/genes11060671.
[3] Akbarnia BA,Gabriel KR,Beckman E,et al.Prevalence of scoliosis in neurofibromatosis[J].Spine (Phila Pa 1976),1992,17(8 Suppl):S244-S248.DOI:10.1097/00007632-199208001-00005.
[4] Gutmann DH,Ferner RE,Listernick RH,et al.Neurofibromatosis type 1[J].Nat Rev Dis Primers,2017,3:17004.DOI:10.1038/nrdp.2017.4.
[5] Calvert PT,Edgar MA,Webb PJ.Scoliosis in neurofibromatosis.The natural history with and without operation[J].J Bone Joint Surg Br,1989,71(2):246-251.DOI:10.1302/0301-620X.71B2.2494186.
[6] Yao ZM,Guo D,Li H,et al.Surgical treatment of dystrophic scoliosis in neurofibromatosis type 1:outcomes and complications[J].Clin Spine Surg,2019,32(1):E50-E55.DOI:10.1097/BSD.0000000000000716.
[7] Wang ZY,Fu CF,Leng JL,et al.Treatment of dystrophic scoliosis in neurofibromatosis type 1 with one-stage posterior pedicle screw technique[J].Spine J,2015,15(4):587-595.DOI:10.1016/j.spinee.2014.10.014.
[8] Bouthors C,Dukan R,Glorion C,et al.Outcomes of growing rods in a series of early-onset scoliosis patients with neurofibromatosis type 1[J].J Neurosurg Spine,2020,33(3):373-380.DOI:10.3171/2020.2.SPINE191308.
[9] Carbone M,Vittoria F,Del Sal A.Treatment of early-onset scoliosis with growing rods in patients with neurofibromatosis-1[J].J Pediatr Orthop B,2019,28(3):278-287.DOI:10.1097/BPB.0000000000000627.
[10] Wu-Chou YH,Hung TC,Lin YT,et al.Genetic diagnosis of neurofibromatosis type 1:targeted next-generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis[J].J Biomed Sci,2018,25(1):72.DOI:10.1186/s12929-018-0474-9.
[11] Jett K,Friedman JM.Clinical and genetic aspects of neurofibromatosis 1[J].Genet Med,2010,12(1):1-11.DOI:10.1097/GIM.0b013e3181bf15e3.
[12] Kehrer-Sawatzki H,Cooper DN.Challenges in the diagnosis of neurofibromatosis type 1(NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants[J].Hum Genet,2022,141(2):177-191.DOI:10.1007/s00439-021-02410-z.
[13] Deng A,Zhang HQ,Tang MX,et al.Posterior-only surgical correction of dystrophic scoliosis in 31 patients with neurofibromatosis type 1 using the multiple anchor point method[J].J Neurosurg Pediatr,2017,19(1):96-101.DOI:10.3171/2016.7.PEDS16125.
[14] Jain VV,Berry CA,Crawford AH,et al.Growing rods are an effective fusionless method of controlling early-onset scoliosis associated with neurofibromatosis type 1(NF1):a multicenter retrospective case series[J].J Pediatr Orthop,2017,37(8):e612-e618.DOI:10.1097/BPO.0000000000000963.
[15] Tauchi R,Kawakami N,Castro MA,et al.Long-term surgical outcomes after early definitive spinal fusion for early-onset scoliosis with neurofibromatosis type 1 at mean follow-up of 14 years[J].J Pediatr Orthop,2020,40(1):42-47.DOI:10.1097/BPO.0000000000001090.
[16] Legius E,Messiaen L,Wolkenstein P,et al.Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome:an international consensus recommendation[J].Genet Med,2021,23(8):1506-1513.DOI:10.1038/s41436-021-01170-5.
[17] Langensiepen S,Semler O,Sobottke R,et al.Measuring procedures to determine the Cobb angle in idiopathic scoliosis:a systematic review[J].Eur Spine J,2013,22(11):2360-2371.DOI:10.1007/s00586-013-2693-9.
[18] Bettegowda C,Upadhayaya M,Evans DG,et al.Genotype-phenotype correlations in neurofibromatosis and their potential clinical use[J].Neurology,2021,97(7 Suppl 1):S91-S98.DOI:10.1212/WNL.0000000000012436.
[19] Pan Y,Hysinger JD,Barron T,et al.NF1 mutation drives neuronal activity-dependent initiation of optic glioma[J].Nature,2021,594(7862):277-282.DOI:10.1038/s41586-021-03580-6.
[20] van Minkelen R,van Bever Y,Kromosoeto JNR,et al.A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands[J].Clin Genet,2014,85(4):318-327.DOI:10.1111/cge.12187.
[21] Ejerskov C,Raundahl M,Gregersen PA,et al.Clinical features and disease severity in patients with mosaic neurofibromatosis type 1:a single-center study and literature review[J].Orphanet J Rare Dis,2021,16(1):180.DOI:10.1186/s13023-021-01796-3.
[22] Sabbagh A,Pasmant E,Laurendeau I,et al.Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1[J].Hum Mol Genet,2009,18(15):2768-2778.DOI:10.1093/hmg/ddp212.
[23] Harder A,Titze S,Herbst L,et al.Monozygotic twins with neurofibromatosis type 1(NF1) display differences in methylation of NF1 gene promoter elements,5’ untranslated region,exon and intron 1[J].Twin Res Hum Genet,2010,13(6):582-594.DOI:10.1375/twin.13.6.582.
[24] Zhu LD,Zhang YF,Tong HX,et al.Clinical and molecular characterization of NF1 patients:single-center experience of 32 patients from China[J].Medicine (Baltimore),2016,95(10):e3043.DOI:10.1097/MD.0000000000003043.
[25] 郭东,姚子明,高荣轩,等.生长棒与早期融合手术治疗早发性Ⅰ型神经纤维瘤病脊柱侧凸的对照研究[J].中华骨与关节外科杂志,2020,13(8):624-629.DOI:10.3969/j.issn.2095-9958.2020.08.02. Guo D,Yao ZM,Gao RX,et al.et al comparative research between growing rod and early spinal fusion surgery for early-onset scoliosis in patients with type 1 neurofibromatosis[J].Chin JBone Joint Surg,2020,13(8):624-629.DOI:10.3969/j.issn.2095-9958.2020.08.02.
[26] Sial M,George KJ.A review of spinal lesions in neurofibromatosis type 1 in a large neurofibromatosis type 1 center[J].World Neurosurg,2023,169:e157-e163.DOI:10.1016/j.wneu.2022.10.100.
[27] Toll BJ,Samdani AF,Janjua MB,et al.Perioperative complications and risk factors in neuromuscular scoliosis surgery[J].J Neurosurg Pediatr,2018,22(2):207-213.DOI:10.3171/2018.2.PEDS17724.
[28] Yao ZM,Li H,Zhang XJ,et al.Incidence and risk factors for instrumentation-related complications after scoliosis surgery in pediatric patients with NF-1[J].Spine (Phila Pa 1976),2018,43(24):1719-1724.DOI:10.1097/BRS.0000000000002720.
[29] Tritz R,Hudson FZ,Harris V,et al.MEK inhibition exerts temporal and myeloid cell-specific effects in the pathogenesis of neurofibromatosis type 1 arteriopathy[J].Sci Rep,2021,11(1):24345.DOI:10.1038/s41598-021-03750-6.
[30] Well L,Careddu A,Stark M,et al.Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI[J].Sci Rep,2021,11(1):16889.DOI:10.1038/s41598-021-96310-x.
[31] Mladenov KV,Spiro AS,Krajewski KL,et al.Management of spinal deformities and tibial pseudarthrosis in children with neurofibromatosis type 1(NF-1)[J].Childs Nerv Syst,2020,36(10):2409-2425.DOI:10.1007/s00381-020-04775-4.
[32] Li Y,Yuan XX,Sha SF,et al.Effect of higher implant density on curve correction in dystrophic thoracic scoliosis secondary to neurofibromatosis type 1[J].J Neurosurg Pediatr,2017,20(4):371-377.DOI:10.3171/2017.4.PEDS171.
Memo
收稿日期:2024-10-11。
基金项目:国家重点研发计划资助(2023YFC2507701);北京市自然科学基金-海淀原始创新联合基金资助项目(L222095)
通讯作者:张学军,Email:zhang-x-j04@163.com;郝婵娟,Email:hchjhchj@163.com